C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma

  1. Roccaro, A.M.
  2. Sacco, A.
  3. Jimenez, C.
  4. Maiso, P.
  5. Moschetta, M.
  6. Mishima, Y.
  7. Aljawai, Y.
  8. Sahin, I.
  9. Kuhne, M.
  10. Cardarelli, P.
  11. Cohen, L.
  12. San Miguel, J.F.
  13. Garcia-Sanz, R.
  14. Ghobrial, I.M.
Aldizkaria:
Blood

ISSN: 1528-0020,  0006-4971

Argitalpen urtea: 2014

Alea: 123

Zenbakia: 26

Orrialdeak: 4120-4131

Mota: Artikulua

DOI: 10.1182/BLOOD-2014-03-564583 GOOGLE SCHOLAR lock_openSarbide irekia editor